Skip to content
Search

Latest Stories

Valproate National Patient Safety Alert – GPhC tells what pharmacists need to do

Valproate National Patient Safety Alert – GPhC tells what pharmacists need to do
Valproate National Patient Safety Alert

Pharmacy teams should be prepared to discuss the current warnings and upcoming measures with their patients

The General Pharmaceutical Council (GPhC) on Thursday sent an email to all pharmacy professionals to update them about a Valproate National Patient Safety Alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA).


From January 2024, the MHRA is introducing the first phase of new regulatory measures to reduce the known harms of valproate, a drug used to treat epilepsy and bipolar disorder.

The health regulator has cautioned that the drug may cause serious harm to the baby, if taken during pregnancy, and lead to impaired fertility in males.

Integrated Care Boards in England and Health Boards in Scotland and Wales have been instructed to designate a new or existing group to prepare for and co-ordinate the implementation of the measures for oversight of prescribing valproate to new patients and existing female patients.

Meanwhile, the GPhC has informed pharmacy teams that they should be prepared to discuss the current warnings and upcoming measures with their patients.

However, pharmacist should continue to dispense valproate, as well as remind patients who are taking the drug that they must not stop taking their treatment without advice from their specialist.

Additionally, the regular have gathered existing resources and information about valproate and made it available on its website to help pharmacists to stay up-to-date.

The GPhC has also appealed to pharmacy teams to spread this important information in the sector.

New regulatory measures for valproate prescribing

The MHRA says:

From January 2024, valproate must not be started in new patients (male or female) younger than 55 years, unless two specialists independently consider and document that there is no other effective or tolerated treatment, or unless there are compelling reasons that the reproductive risks do not apply. For the majority of patients, other effective treatment options are available.

Women of childbearing potential and and girls who are currently taking valproate should be reviewed at their next annual specialist review, using a revised valproate Annual Risk Acknowledgement Form, which will include the need for a second opinion’s signature if the patient is to continue with valproate.

The regulatory measures will be introduced in a phased manner to ensure ongoing patient care is not disrupted, as recommended by the independent group Commission on Human Medicines

 

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less